A Randomized Controlled Trial on the Hemodynamic and Molecular Responses to Lidocaine with Epinephrine Versus Mepivacaine in Hypertensive Patients Undergoing Dental Extraction
Abstract: Background:The use of local anesthetics with vasoconstrictors in hypertensive patients undergoing dental procedures remains a clinical concern due to potential adverse cardiovascular events. This study aimed to provide a comprehensive comparison of the hemodynamic, inflammatory, and genetic responses to lidocaine with epinephrine versus plain mepivacaine in controlled hypertensive patients undergoing tooth extraction. Materials and Methods:This prospective, randomized, double-blind clinical trial included 80 controlled hypertensive patients scheduled for tooth extraction. Patients were randomly assigned to receive either 2% lidocaine with 1:80,000 epinephrine (Group L, n=40) or 3% mepivacaine plain (Group M, n=40). Hemodynamic parameters (systolic blood pressure [SBP], Diastolic Blood Pressure [DBP], Heart Rate [HR]) were recorded at baseline, 3 minutes post-injection, and 3 minutes post-extraction. Venous blood samples were collected at baseline and 30 minutes post-extraction to analyze inflammatory biomarkers (hs-CRP, IL-6, TNF-α) and for genotyping of CYP1A2 and ADRB2 polymorphisms. Results: Group L demonstrated significantly greater hemodynamic stability, with smaller fluctuations in SBP and HR compared to Group M (p<0.05). Post-procedure, Group M showed a significant increase in serum hs-CRP and IL-6 levels (p<0.01), whereas Group L showed no significant change. Patients with the CYP1A2 *1F allele (A/A genotype) showed slower lidocaine metabolism and a transient increase in DBP. A significant association was found between the ADRB2 Gly16Arg polymorphism and increased HR variability in both groups. Discussion:The finding of more significant hemodynamic instability and inflammatory response within the mepivacaine group suggests that inadequate anesthesia causes a substantial endogenous catecholamine stress response, which is likely more damaging than a minimal amount of exogenous epinephrine. Additionally, genetic differences in CYP1A2 and ADRB2 influence individual physiologic responses and support a biological explanation for the variability is seen across patients. Conclusion: Lidocaine with epinephrine was associated with superior hemodynamic stability and a blunted systemic inflammatory response compared to plain mepivacaine. These findings suggest that the inclusion of a vasoconstrictor may offer a safer and more controlled anesthetic profile for hypertensive patients. Pharmacogenetic variations in CYP1A2 and ADRB2 may influence individual patient responses, highlighting the potential for personalized anesthetic